Yep. The possibilities are either (a) ineptitude/overpromising/inability to meet a deadline or (b) the scoping study is so unfavourable that it's better to delay and try to improve it than to release, even at the cost of shredding credibility. Both terrible options.
- Forums
- ASX - By Stock
- E25
- Ann: Butcherbird Manganese Project Operational Update
E25
element 25 limited
Add to My Watchlist
4.44%
!
21.5¢

Ann: Butcherbird Manganese Project Operational Update, page-73
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.5¢ |
Change
-0.010(4.44%) |
Mkt cap ! $49.15M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.71K | 99.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2782 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 64581 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2788 | 0.215 |
5 | 95393 | 0.210 |
4 | 339200 | 0.205 |
7 | 59405 | 0.200 |
5 | 574077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 64579 | 5 |
0.230 | 73923 | 2 |
0.235 | 24800 | 2 |
0.240 | 255584 | 3 |
0.245 | 21276 | 1 |
Last trade - 15.55pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online